Enovis (ENOV) Cash & Equivalents (2010 - 2026)

Enovis (ENOV) has 17 years of Cash & Equivalents data on file, last reported at $33.1 million in Q2 2026.

• On a quarterly basis, Cash & Equivalents fell 13.86% year-over-year to $33.1 million in Q2 2026; TTM through Apr 2026 was $33.1 million, a 13.86% decrease from a year earlier, with the FY2025 full-year figure at $36.4 million, down 24.45% from the prior year.
• Cash & Equivalents for Q2 2026 stood at $33.1 million, down from $36.4 million in the prior quarter.
• Over the last five years, Cash & Equivalents for ENOV reached as high as $661.5 million in Q2 2022 and fell as low as $21.9 million in Q1 2023.
• Historically, Cash & Equivalents has averaged $78.2 million across 5 years, with a median of $36.2 million in 2023.
• Across the five-year window, Cash & Equivalents sank 96.69% in 2023 and surged 202.59% in 2024, its largest moves.
• Year by year, Cash & Equivalents stood at $24.3 million in 2022, then soared by 48.96% to $36.2 million in 2023, then soared by 33.09% to $48.2 million in 2024, then slipped by 24.45% to $36.4 million in 2025, then fell by 8.96% to $33.1 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $33.1 million in Q2 2026, $36.4 million in Q4 2025, and $33.6 million in Q4 2025.